Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer
The purpose of this study is to determine efficacy of SB injection in Gastric Cancer.
Gastric Cancer
DRUG: SB injection
Evaluating Tumor Response Rate, 4 months
Pain Scores on the Visual Analog Scale, 4 months|Evalute patient's performance by measuring Eastern Cooperative Oncology Group scale, 4 months|Determine duration of response rate by measuring time to progression, 4 months
All eligible patients will receive SB injection therapy for 6 cycles (14\~21 days for each cycle). Efficacy will be evaluated every 3 cycles.